Back to search

Article

Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer

2020-08-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>To develop and validate a prediction model for the pathological complete response (pCR) to neoadjuvant chemotherapy (NCT) of triple-negative breast cancer (TNBC).<bold>Methods: </bold>We systematically searched Gene Expression Omnibus, ArrayExpress, and PubMed for the gene expression profiles of operable TNBC accessible to NCT. The molecular heterogeneity was de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
40577674-8566-5fe7-a5dd-6fd1eb0dbcf8
DOI
10.21203/rs.3.rs-54094/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerDOI 10.21203/rs.3.rs-54094/v1
The analysis of transcriptomic signature of TNBC – searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivitySemantic proximity
Development of a Prognostic Model Based on Identification of EMT-related LncRNAs in Triple Negative Breast CancerSemantic proximity
FDG-PET/CT and multimodal machine learning model prediction of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity
Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer - one clinic experience.Semantic proximity
Development and External Validation of a Transcriptomic Prognostic Signature in Triple-Negative Breast Cancer Treated with Neoadjuvant ChemotherapySemantic proximity
The Early-Stage Triple-Negative Breast Cancer Landscape Derives a Novel Prognostic Signature and Therapeutic TargetSemantic proximity
New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity
An 8-lncRNA Signature Predicts Survival of Triple-Negative Breast Cancer Patients Without Germline BRCA1/2 MutationSemantic proximity
Malignant cell related gene signature for patients with triple-negative breast cancer based on integrated analysis of single cell and bulk RNA sequencingSemantic proximity
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity
An 8-lncRNA signature predicts survival of triple-negative breast cancer patients without germline BRCA1/2 mutationSemantic proximity
Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional ValidationSemantic proximity
Select a neighboring publication to make it the new centre.